SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddys reports 17% fall in Q2 consolidated net profit

29 Oct 2014 Evaluate

Dr. Reddys Laboratories has reported results for second quarter ended September 30, 2014.

The company has registered 43.94% fall in its net profit at Rs 433.59 crore for the quarter under review as compared to Rs 773.38 crore for the same quarter in the previous year. Total income of the company has decreased 7.48% at Rs 2535.62 crore for Q2FY15 as compared Rs 2740.90 crore for the corresponding quarter previous year.

On consolidated basis, the company’s net profit for the quarter under review declined 16.83% at Rs 574.10 crore against Rs 690.25 crore in the September quarter of previous fiscal. However, the company’s total income has increased by 5.65% at Rs 3614.37 crore for the quarter from Rs 3421.12 crore in the similar quarter of previous year.

Dr. Reddys Lab Share Price

1292.00 -1.25 (-0.10%)
11-May-2026 14:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.20
Dr. Reddys Lab 1292.00
Cipla 1313.50
Zydus Lifesciences 955.20
Lupin 2279.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×